Jubilant Pharmova Ltd - Company Profile
Powered by 
All the data and insights you need on Jubilant Pharmova Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Jubilant Pharmova Ltd Strategy Report
- Understand Jubilant Pharmova Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Jubilant Pharmova Ltd (Jubilant) is an integrated pharmaceutical and life sciences company which provides pharmaceuticals, life science ingredients, and drug discovery solutions. The company’s product portfolio includes radiopharmaceuticals, allergy therapy products, active pharmaceutical ingredients (APIs), solid dosage formulations, life science chemicals, nutritional products, fine ingredients, advance intermediates and crop science ingredients. It also provides contract manufacturing of sterile injectables and drug discovery and development services in various fields. The company caters its products and services to customers across India, North America, Canada, Europe, and China. It owns and operates cGMP compliant manufacturing facilities, and research and development centers in India, the US and Canada. Jubilant is headquartered in Noida, Uttar Pradesh, India.
Headquarters
India
Address
1a, Sector 16a, Noida, Uttar Pradesh, 201301
Website
www.jubl.com
Telephone
91 120 4361000
No of Employees
1,034
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
JUBLPHARMA (NSE)
Revenue (2022)
$800.5M
2.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-114.7%
(2022 vs 2021)
Market Cap*
$1.3B
Net Profit Margin (2022)
XYZ
-114.4%
(2022 vs 2021)
* As of and is in US$
Jubilant Pharmova Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Life Science Ingredients: | Drug Discovery Solutions: | JUBI-R |
| Advance Intermediates: | Discovery | |
| Pyridine and Picoline | Bioinformatics (pathart) | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Acquisitions/Mergers/Takeovers | In March, the company acquired a stake in O2 Renewable Energy XVI. |
| 2023 | Contracts/Agreements | In September, Jubilant DraxImage Inc entered into a partnership with Cardiac Imaging to provide a daily-leased rubidium solution to healthcare facilities interested in performing cardiac PET. |
| 2023 | Regulatory Approval | In March, Jubilant HollisterStier received approval from the Government of Canada to provide through its Strategic Innovation Fund (SIF) program to fund the CAD 108 million capacity expansion at the Montreal manufacturing facility. |
Competitor Comparison
| Key Parameters | Jubilant Pharmova Ltd | Teva Pharmaceutical Industries Ltd | Dr. Reddy's Laboratories Ltd | Tata Chemicals Ltd | BASF India Ltd |
|---|---|---|---|---|---|
| Headquarters | India | Israel | India | India | India |
| City | Noida | Tel Aviv | Hyderabad | Mumbai | Navi Mumbai |
| State/Province | Uttar Pradesh | Tel Aviv | Telangana | Maharashtra | Maharashtra |
| No. of Employees | 1,034 | 35,001 | 24,832 | 4,622 | 1,378 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Shyam S. Bhartia | Chairman | Executive Board | - | - |
| Hari S. Bhartia | Managing Director; Co-Chairman | Executive Board | - | 67 |
| Arvind Chokhany | Director; Group Chief Financial Officer | Executive Board | 2021 | 51 |
| Shantanu Jha | Chief Human Resources Officer | Senior Management | 2023 | - |
| Jaidev S. Rajpal | Managing Director; Chief Executive Officer - Jubilant Generics Limited | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer